Medeor Therapeutics
South San Francisco
About Medeor Therapeutics
Medeor Therapeutics is a developer of cellular immunotherapies designed to improve outcomes in organ transplant recipients. The company's cellular immunotherapies consist of approaches to organ transplant immune tolerance and immuno-oncology, enabling healthcare providers to preserve or improve transplant kidney function and prevent graft rejection better than currently available immunosuppression (anti-rejection) drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $75.8M
- Funding stage: Early Stage Venture
- Last round: Grant (Jan 2018)
- Website: medeortx.com
- Phone: 650-627-4531
Industries & Categories
Biotechnology, Pharmaceutical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/medeor-therapeutics-71671 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.